Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center.
Jachs M, Sauberer R, Stiegler A, Dechêne A, Tazreiter R, Hartl L, Bauer D, Balcar L, Strassl R, Mandorfer M, Trauner M, Munda P, Ferenci P, Reiberger T. Jachs M, et al. Among authors: munda p. United European Gastroenterol J. 2023 Apr;11(3):293-304. doi: 10.1002/ueg2.12376. Epub 2023 Mar 25. United European Gastroenterol J. 2023. PMID: 36965148 Free PMC article.
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis.
Jachs M, Binter T, Schmidbauer C, Hartl L, Strasser M, Laferl H, Hametner-Schreil S, Lindorfer A, Dax K, Stauber RE, Kessler HH, Bernhofer S, Maieron A, Loacker L, Bota S, Santonja I, Munda P, Mandorfer M, Peck-Radosavljevic M, Holzmann H, Gschwantler M, Zoller H, Ferenci P, Reiberger T. Jachs M, et al. Among authors: munda p. United European Gastroenterol J. 2021 Dec;9(10):1119-1127. doi: 10.1002/ueg2.12163. Epub 2021 Dec 7. United European Gastroenterol J. 2021. PMID: 34873866 Free PMC article.
Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" study.
Jachs M, Schwarz C, Panzer M, Binter T, Aberle SW, Hartl L, Dax K, Aigner E, Stättermayer AF, Munda P, Graziadei I, Holzmann H, Trauner M, Zoller H, Gschwantler M, Mandorfer M, Reiberger T, Ferenci P. Jachs M, et al. Among authors: munda p. Aliment Pharmacol Ther. 2022 Jul;56(1):144-154. doi: 10.1111/apt.16945. Epub 2022 May 5. Aliment Pharmacol Ther. 2022. PMID: 35514008 Free PMC article.
Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease.
Paternostro R, Staufer K, Traussnigg S, Stättermayer AF, Halilbasic E, Keritam O, Meyer EL, Stift J, Wrba F, Sipos B, Canbay A, Schlattjan M, Aigner E, Datz C, Stickel F, Schafmayer C, Hampe J, Buch S, Prager G, Munda P, Mandorfer M, Ferenci P, Trauner M. Paternostro R, et al. Among authors: munda p. Hepatol Int. 2021 Aug;15(4):922-933. doi: 10.1007/s12072-021-10200-y. Epub 2021 Jun 2. Hepatol Int. 2021. PMID: 34076851 Free PMC article.
Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease.
Traussnigg S, Halilbasic E, Hofer H, Munda P, Stojakovic T, Fauler G, Kashofer K, Krssak M, Wolzt M, Trauner M. Traussnigg S, et al. Among authors: munda p. Wien Klin Wochenschr. 2021 May;133(9-10):441-451. doi: 10.1007/s00508-020-01735-5. Epub 2020 Sep 15. Wien Klin Wochenschr. 2021. PMID: 32930860 Free PMC article. Clinical Trial.
26 results